19 results
424B5
ABOS
Acumen Pharmaceuticals Inc
20 Jul 23
Prospectus supplement for primary offering
4:11pm
they agree to do so in their customer agreements or because they are legally required to do so. Investors who hold securities in street name
8-K
EX-1.1
92xh ugwnx
20 Jul 23
Entry into a Material Definitive Agreement
4:06pm
424B5
cnu 6h9xvenxb
17 Jul 23
Prospectus supplement for primary offering
4:49pm
S-3
zjjj7v92n003o
1 Jul 22
Shelf registration
5:06pm
S-3
EX-1.2
ap6px dtijpzpwb
1 Jul 22
Shelf registration
5:06pm
10-K
8jzerajw
28 Mar 22
Annual report
4:51pm
10-Q
gkq78 tpmwm1
16 Aug 21
Quarterly report
4:51pm
424B4
zvpkcenm5 igs9voz28e
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
EX-1.1
9g1tjf
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
EX-10.2
c749k7mh
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
84ehthyw 8w1gnp
24 Jun 21
IPO registration (amended)
8:17am
S-1
r17ly2qw3sqkfcr36
9 Jun 21
IPO registration
5:02pm
DRS/A
zci9t 213g
14 May 21
Draft registration statement (amended)
12:00am
DRS
km29qfj
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next